Highest Score

Ranked by analysis score
Ranks this page's recent reports by score.
Core Scientific, Inc.
CORZ·Technology
C ★★Sell
Current$13.25
Oct 31, 2026

Core Scientific could become a major contracted AI data-center infrastructure provider through rapid power-capacity activation, but heavy construction spending, debt, and uncertain free cash flow threaten equity returns.

Score
59
ICON Public Limited Company
ICLR·Healthcare
C ★★Sell
Current$209.37
Oct 30, 2026

ICON's global CRO franchise, $24.5B backlog, and strong cash generation provide recovery potential, but unresolved accounting-control weaknesses and weak organic growth outweigh its relative valuation discount.

Score
59
Tootsie Roll Industries, Inc.
TR·Consumer Staples
C ★★Sell
Current$34.78
Oct 24, 2026

Tootsie Roll's iconic candy brands and debt-light balance sheet underpin a durable consumer franchise, but flat sales, persistent cost inflation, and demanding cash-flow valuation limit the investment appeal.

Score
59
THOR Industries, Inc.
THO·Consumer Discretionary
D ★Strong Sell
Current$72.15
Sep 27, 2026

THOR's scale, strong balance sheet and targeted $100M-plus cost savings create meaningful recovery potential, but weak RV affordability and a premium earnings multiple leave too little margin of safety before margins visibly recover.

Score
59
lululemon athletica inc.
LULU·Consumer Discretionary
D ★Strong Sell
Current$98.97
Sep 14, 2026

lululemon's premium brand, cash generation and depressed valuation offer turnaround upside, but double-digit Americas comp declines and falling earnings estimates make value-trap risk too high until momentum stabilizes.

Score
59
Figma, Inc.
FIG·Technology
C ★★Sell
Current$25.20
Aug 11, 2026

Figma commands the digital design monopoly with massive accelerating growth, but an impending 140M-share lock-up expiration, aggressive C-suite insider selling, and 35% short interest make the stock fundamentally uninvestable in the near term.

Score
59
FedEx Freight Holding Company, Inc.
FDXF·Industrials
C ★★Sell
Current$126.04
Nov 1, 2026

FedEx Freight's leading North American LTL network offers long-term margin recovery potential, but demanding valuation, cyclical freight weakness, and substantial post-spin leverage constrain its near-term investment appeal.

Score
58
Ultragenyx Pharmaceutical Inc.
RARE·Healthcare
C ★★Sell
Current$16.10
Nov 1, 2026

Ultragenyx has meaningful growth potential from approved rare-disease therapies and new gene therapy launches, but persistent cash burn, substantial financing obligations, and clinical execution risk undermine the near-term investment case.

Score
58
Alignment Healthcare, Inc.
ALHC·Healthcare
C ★★Sell
Current$7.27
Nov 1, 2026

Alignment Healthcare has substantial long-term Medicare Advantage growth potential through differentiated senior-care delivery, but worsening medical costs and reduced profit guidance threaten the conversion of membership gains into durable earnings.

Score
58
Hyatt Hotels Corporation
H·Consumer Discretionary
C ★★Sell
Current$180.57
Nov 1, 2026

Hyatt's premium hotel brands and growing asset-light fee platform offer attractive long-term cash-flow potential, but a demanding valuation and substantial leverage limit the margin of safety.

Score
58
OGE Energy Corp.
OGE·Utilities
C ★★Sell
Current$49.47
Nov 1, 2026

OGE Energy offers durable regulated electricity revenue, a stable dividend, and infrastructure-led growth opportunities, but elevated valuation, heavy capital spending, and potential dilution constrain shareholder returns.

Score
58
Red Rock Resorts, Inc.
RRR·Consumer Discretionary
C ★★Sell
Current$49.15
Oct 31, 2026

Red Rock Resorts owns a defensible Las Vegas locals casino franchise with valuable expansion opportunities, but elevated leverage, weakening near-term profitability, and a historically expensive enterprise valuation constrain investment appeal.

Score
58